Profund Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Profund Advisors’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-38,127	Closed	-$1.46M	–	1099
2023 Q2	$1.46M	Buy	38,127 +4,203	+12%	+$108K	0.08%	217
2023 Q1	$785K	Buy	+33,924	New	+$809K	0.05%	369

Profund Advisors's KDNY Position: Q3 2023 in Review

Profund Advisors sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 38,127 shares — an estimated $1.46M sold.

Profund Advisors first reported a position in KDNY in Q1 2023 and held it in 2 quarters. The position peaked at $1.46M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Profund Advisors reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Profund Advisors sold 38,127 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.46M.
Profund Advisors first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Profund Advisors's Chinook Therapeutics, Inc. Common Stock position peaked at $1.46M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Profund Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.